Compartir
Título
Complexation of the non-steroidal anti-inflammatory drug Nabumetone with modified and unmodified cyclodextrins
Autor(es)
Palabras clave
Nabumetone
Naproxen
Cyclodextrin
UV-absorption spectroscopy
Fluorescence spectroscopy
Thermodynamics
Proton NMR
Fecha de publicación
1999
Editor
Springer
Citación
Valero, M., Costa, S. M. B., Ascenso, J. R., Velázquez, M. M., & Rodríguez, L. J. (1999). Complexation of the non-steroidal anti-inflammatory drug Nabumetone with modified and unmodified cyclodextrins. Journal of Inclusion Phenomena, 35(4), 663-677. https://doi.org/10.1023/A:1008011228459
Resumen
[EN]The inclusion of the anti-inflammatory drug, Nabumetone, in α-, β-and hydroxypropylβ-cyclodextrin (CDs) is studied using UV-VIS absorption and steady-state fluorescence emission. Binding constants and thermodynamic parameters of complex formation are determined by spectrofluorimetry. The inclusion phenomena of Nabumetone with the three cyclodextrins is compared with that of the well known similar anti-inflammatory drug Naproxen. In the case of Nabumetone pronounced differences are observed in the complexation process with each cyclodextrin whereas the respective Naproxen complexes are nearly identical. 1H-NMR experiments show that the inclusion process in Nabumetone can occur either through the substituents in the -2 (butanone) or -6 (methoxy) positions in the naphthalene ring.
URI
ISSN
1388-3127
DOI
10.1023/A:1008011228459
Versión del editor
Aparece en las colecciones
Ficheros en el ítem
Tamaño:
119.1Kb
Formato:
Adobe PDF












